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Matthew Jose Justice 
THE ROLE OF ACID SPHINGOMYELINASE IN AUTOPHAGY 
 Autophagy is a conserved cellular process that involves sequestration and 
degradation of cytosolic contents. The cell can engulf autophagic cargo (lipids, long-lived 
proteins, protein aggregates, and pathogens) through a double bound membrane called 
an autophagosome that fuses with a lysosome where hydrolases then degrade these 
contents. This process is one of the main defenses against starvation and is imperative 
for newborns at birth. Research on this process has increased exponentially in the last 
decade since its discovery almost a half a century ago. It has been found that autophagy 
is an important process in many diseases, continues to be at the forefront of research, 
and is clearly not fully understood. Our preliminary cell culture data in endothelial and 
epithelial cells show that a blockade of the de novo ceramide synthesis pathway, during 
treatment with an autophagy stimulus (cigarette smoke extract exposure), does not 
result in any reduction in autophagy or autophagic flux. Conversely, when acid 
sphingomyelinase (ASM) is pharmacologically inhibited, which prevents the generation 
of ceramide from sphingomyelin in an acidic environment, a profound increase in 
autophagy is observed. In this work, we hypothesize that (ASM) is an endogenous 
inhibitor of autophagy. ASM has two forms, a secreted form and a lysosomal form. N-
terminal processing in the Golgi determines its cellular fate. In the lysosomal form, the 
phosphodiesterase is bound in the lysosomal membrane. The pharmacological inhibition 
mechanism is to release ASM from the membrane and allow other hydrolases to 
actively degrade the enzyme which, in turn, decreases the activity of ASM. This suggests 
v 
 
that either the activity of ASM is a regulator of autophagy or that the presence of ASM, 
activity aside, is required for the lysosomal nutrient sensing machinery (LYNUS) to 
function properly. Here, we show that ASM is, in fact, an endogenous inhibitor of 
autophagy in vitro. The phosphorylation status of P70 S6k, a downstream effector of 
mammalian target of rapamycin (mTOR), which is part of the LYNUS, shows that 
dissociation of ASM from the membrane regulates mTOR and disturbs the LYNUS in such 
a manner as to signal autophagy. 
Irina Petrache, M.D., Chair 
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Introduction 
 Autophagy is a fundamental cellular process in which intracellular contents can 
be sequestered, degraded, and re-utilized to meet energy demands during periods of 
nutrient deprivation [1]. This process can be responsible for the degradation of long-
lived proteins, lipids, protein aggregates, organelles, and even pathogens [2]. When this 
process is signaled, a double-bound membrane, a phagophore, starts forming around 
the contents to be degraded and, eventually, totally enclosing the contents and 
becoming a mature autophagosome [3]. This autophagosome will then fuse with a 
lysosome creating an autophagolysosome which will, in turn, degrade the cargo that has 
been supplied. The total process of autophagy, from formation of phagophore to 
degradation of autophagolysosome, has many steps with many autophagy related 
proteins (ATG) associated with each step. Proper evaluation of autophagic induction 
versus autophagic flux is imperative when evaluating this process [4]. 
 Homeostatic autophagy is important for tissue function especially during stress, 
starvation, or infections [5]. Impaired or persistent autophagy may be pathogenic, 
leading to cell death and may play a role in various diseases such as cancer, metabolic, 
pulmonary, cardiovascular, and neurodegenerative diseases [5]. Emphysema, a 
pulmonary disease, is primarily caused by chronic cigarette smoking and is characterized 
by excessive apoptosis of structural cells of the lung such as endothelial cells and 
epithelial cells [6]. Recently, autophagy with decreased flux induced by cigarette smoke 
has been shown to be pathogenic in emphysema and to precede apoptosis [7]. Lungs 
with emphysema have increased levels of ceramide, a bioactive sphingolipid that has 
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been implicated in apoptosis [6]. There are reports in the literature that ceramide may 
also trigger autophagy [8]. To determine the importance of ceramide production in 
human lung structural cell autophagy, we focused on the enzyme acid sphingomyelinase 
(ASM), which produces ceramide from sphingomyelin. Two forms of ASM exist, a 
secreted and a lysosomal form that arise from the same protein precursor with 
destination determined by mannose-6-phosphate tagging and serine 508 
phosphorylation [9]. In this work, we will focus only on the lysosomal form. The 
inhibition of ASM did not inhibit CS induced autophagy but rather markedly increased 
the formation of autophagolysosomes. That led us to the hypothesis that ASM, an 
enzyme that is responsible for producing pro-apoptotic ceramides, is an endogenous 
inhibitor of autophagy. 
 To investigate our hypothesis, we used imipramine a pharmacological inhibitor 
of ASM with an indirect mechanism of action [10]. Rather than a direct enzymatic 
inhibitor, imipramine through diffusion and hydrophobicity, aggregates in lysosomes 
and, through its organic weak base properties, dissociates ASM from the inner 
lysosomal membrane and allows quick proteolytic degradation of the enzyme leading to 
diminished activity [11]. 
 To understand the mechanisms by which ASM may regulate autophagy, we 
focused on a major signaling pathway involved in autophagy, linking growth factor 
signaling to the machinery responsible for cell metabolism and proliferation [12]. This 
pathway is centered around the mammalian target of rapamycin (mTOR), a 
serine/threonine kinase that regulates cell growth, proliferation, and protein synthesis, 
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itself regulated by phosphor inositol-3-kinase (PI3k) and Akt activation [12]. Activation 
of Akt itself also serves to inhibit apoptosis by binding to BAX [13]. The resident location 
of mTOR in the cell is in the lysosomal nutrient sensing complex which is docked at the 
membrane of the lysosome [14]. If either availability of amino acids is limited or mTOR is 
not docked at the membrane, mTOR will not phosphorylate its downstream targets, halt 
translation and cell cycle, and will induce autophagy [15].  
 In this study, we show that ASM inhibition via imipramine leads to induction of 
autophagy in lung endothelial and epithelial cells, without decreasing the autophagic 
flux, moderately inhibiting proliferation and causing modest levels of apoptosis 
associated with inhibition of mTOR signaling (Figure 1). Elucidating the function of ASM 
as a stress-induced pro-apoptotic enzyme and concomitant endogenous inhibitor of 
autophagy may clarify the crosstalk between autophagy and apoptosis in health and 
disease. 
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Methods 
Reagents 
 Unless otherwise stated, all reagents were purchased from Sigma-Aldrich (St. 
Louis, MO). 
Cell Culture 
 Human immortalized bronchial epithelial cells (BEAS2b), were kindly provided by 
Dr. Augustine Choi (originally from ATCC), and cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with 15% fetal bovine serum 
(FBS) (Thermo Fisher Scientific, Waltham, MA) and 1% penicillin/streptomycin. Primary 
human pulmonary artery endothelial cells (HPAEC) (Invitrogen) were cultured in 
Medium 200 (Invitrogen) containing Low Serum Growth Supplement (Invitrogen). Cells 
were kept in an incubator at 37°C and 100% humidity with 5% CO2. 
 For experiments, cells were grown in D100 dishes to 50-90% confluency.  BEAS2b 
cells received media change of DMEM containing 2% FBS to simulate a low serum 
environment 2 hours prior to experimental procedures.  HPAEC cells received fresh 
media at the time of experiment. Pre-treatments with the PI3k inhibitor, LY294002 
(VWR, Radnor, PA) suspended in ethanol, and autophagsomal degradation inhibitor, 
chloroquine diphosphate (Thermo Fisher Scientific) suspended in water, were 
performed 1 hour prior to treatments with the ASM inhibitor imipramine (Calbiochem, 
San Diego, CA) suspended in water, and the autophagy inducer rapamycin, suspended in 
ethanol. 
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Immunoblotting 
 Cells were washed with ice-cold phosphate buffered saline (PBS) (Thermo Fisher 
Scientific) and gently scraped in ice-cold PBS and centrifuged at 20,000g for 10 minutes 
at 4°C. The PBS was then removed by aspiration, leaving a cell pellet that was snap-
frozen in liquid nitrogen. Cell pellets were thawed on ice and lysed in a buffer containing 
1% Triton-x (Thermo Fisher Scientific), 50mM TRIS (Invitrogen), and 150mM NaCl 
(Thermo Fisher Scientific). Cells were vortexed every 30 minutes for two hours on ice, 
centrifuged at high speed for 10 minutes at 4°C, supernatants removed, and the 
bicinchoninic acid assay (Peirce, Rockford, IL) was performed to determine total protein 
concentrations. Equal protein amounts between 5-20µg, were diluted with Laemmli 4X 
buffer (Boston Bioproducts, Ashland, MA) that contains sodium dodecyl sulfate and 
resolved by electrophoresis using Criterion 4-20% TGX pre-cast gels (Bio-Rad, Hercules, 
CA). Proteins were transferred to polyvinylidene fluoride membranes using a semi-dry 
transfer apparatus (Bio-Rad). Membranes were probed using the following primary 
antibodies (Cell Signaling, Beverly, MA, unless otherwise stated):  phospho-P70 S6K 
(1:1,000), LC3B (1:20,000) (Sigma-Aldrich), P62-lck ligand (1:500) (BD Biosciences, San 
Jose, CA) and vinculin (1:20,000) (Calbiochem) or β-Actin (1:20,000) (Sigma-Aldrich) that 
was used as loading control. Appropriate secondary antibodies (ECL anti-rabbit or anti-
mouse whole antibody horse radish peroxidase) (Thermo Fisher Scientific) (1:10,000) 
were used with ECL Prime/ECL Plus (Thermo Fisher Scientific) for chemiluminescent 
reactions.  Images were taken using a ChemiDoc (Bio-Rad) XRS system with Image Lab 
software. 
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Electron Microscopy 
 Cells were washed with ice cold PBS solution and fixed in a 0.1M phosphate 
buffer solution containing two percent glutaraldehyde and two percent 
paraformaldehyde for 30 minutes at room temperature. Cells were then washed twice 
with PBS and gently scraped in PBS, centrifuged at high speed for 10 minutes and then 
transferred to the Electron Microscopy Core Facility at IU School of Medicine for 
embedding, cutting, and mounting on slides. Images were taken with a Tecnai G2 12 Bio 
Twin (FEI, Hillsboro, OR) equipped with an AMR CCD (Advanced Microscopy Techniques, 
Danvers, MA). 
Cell Viability and Proliferation Assays 
 For the cell counting kit-8 (CCK-8) assay, cells were plated in a 96-well tissue 
culture plate at 5,000 cells per well and allowed to grow for 24 hours before treatment. 
Cells were then treated with CCK-8 reagent (Dojindo, Rockville, MD), a highly water-
soluble tetrazolium salt, for 3 hours and then optical density at 450nm was determined 
by a micro-plate reader. 
 For the thymidine incorporation assay, cells were plated in a 96-well tissue 
culture plate and allowed to grow for 24 hours. Media (5 mL per treatment) was 
prepared and 125µL RPMI (Thermo Fisher Scientific) containing tritiated thymidine 
(Perkin Elmer, Waltham, MA; 1mL of tritiated thymidine in 24mL RPMI) was added. 
Media was then changed (200µL) in the 96-well plate and 25µL of tritiated thymidine 
(1µCi) in RPMI was added to each well. Following 24 hours of treatment, media was 
removed, and cells were washed with PBS, detached using TrypLE Select (Invitrogen), 
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and measured for radioactive thymidine incorporation via scintillation counting on a 
Wallac Microbeta (Boston, MA) 1450 Liquid Scintillation Counter. This experiment was 
performed in collaboration in Dr. Janice Blum’s lab with special thanks to Lynette 
Guindon for performing the assay. 
 For the cell apoptosis assay (Annexin V staining), Cells were grown and treated in 
D100 dishes. Twenty minutes prior to assay, 400uL of 30% hydrogen peroxide was 
added to an untreated dish as positive control for apoptotic and necrotic gate 
parameters of the flow cytometer. Following harvesting, cells were stained for 
phosphatidylserine using Annexin V staining (Annexin V Kit 250 Samples; VWR), 
following manufacturer’s protocol of washing cells in unicellular suspension with PBS 
containing calcium, magnesium, and 2% bovine serum albumin. Propidium iodide (PI) 
and fluorescently labeled Annexin V antibodies were then incubated for ten minutes in 
manufacturer’s supplied binding buffer. Apoptosis was quantified by Annexin V/PI 
staining using a Cytomics FC500 cytofluorimeter (Beckman Coulter, Fullerton, CA) with 
CXP software. Special thanks to Daniela Petrusca for performing the assay. 
Acid Sphingomyelinase Activity 
 Cells were grown and treated in D100 dishes with 50µM imipramine for four 
hours and the Amplex Red Sphingomyelinase Activity Kit (Invitrogen) was applied per 
manufacturer’s protocol and fluorescence determined by a micro-plate reader. 
  
8 
 
Densitometry 
 All densitometry was performed using ImageJ software (Rasband, W.S., ImageJ, 
U. S. National Institutes of Health, Bethesda, MD, USA, http://imagej.nih.gov/ij/, 1997-
2012). 
Statistical Analysis 
 All statistical analyses of experiments with n ≥ 3 were performed with The R 
Project for statistical computing (R Core Team (2013). R: A language and environment 
for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL 
http://www.R-project.org/). When comparing 2 groups, a Welch Two Sample t test was 
used. When comparing multiple groups, a one-way ANOVA was performed with Tukey 
Honest Significant Difference post-hoc test with a p-value cutoff of 0.05 for significance. 
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Results 
Disruption of ASM activation induces autophagy in a time- and dose-dependent 
manner in HPAEC 
 To investigate if autophagy is induced in a dose-dependent manner by 
pharmacological disruption and subsequent inhibition of ASM function with imipramine 
(Figure 2), we performed cell culture experiments using increasing doses of imipramine 
for 4 hours and probed total cell lysates for protein markers of autophagy via western 
blotting (Figure 3A). The onset of autophagy is typically marked by increased conversion 
of LC3B-I to LC3B-II via lipidation. We noted higher levels of LC3B-II following treatment 
with 50 or 100µM imipramine. Interestingly, concentrations of 200µM imipramine 
caused visible cell death and were not further analyzed. The western blot results were 
then quantified by densitometry (Figure 3B), which showed a statistical significance (p ≤ 
0.01) between 50µM and vehicle or 5µM imipramine concentrations. Similarly, 
imipramine concentrations of 100µM dose showed a statistically significant increase (p 
≤ 0.001) of LC3B-II compared to vehicle, 50µM dose, or 5µM. To investigate the kinetics 
of imipramine-induced autophagy, we performed cell culture experiments with 50µM 
imipramine at various time points (Figure 3C). These results have been quantified by 
densitometry, which demonstrated statistical significance (p ≤ 0.01) between 
imipramine treatment and vehicle at both 4 hour and 24 hour time-points (Figure 3D). 
ASM inhibition-induced autophagy is not cell-type specific 
 To determine if ASM inhibition induces autophagy in other human cell types, we 
investigated lung bronchial epithelial cells using the BEAS2b cell line. Imipramine 
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treatment induced similar marked increases in LC3B-II versus vehicle in epithelial cells 
(Figure 4A) as we noted in endothelial cells. Quantification by densitometry showed 
statistically significant increase in LC3B-II accumulation (p ≤ 0.05) (Figure 4B). To further 
confirm the presence of autophagy induced by imipramine, we performed electron 
microscopy to visualize intracellular morphological changes pathognomonic for 
autophagy (Figure 4C). In the vehicle-treated control conditions, we noted normal 
cellular morphology, with healthy appearing endoplasmic reticulum (e), nuclei (n), and 
mitochondria (m). In the imipramine treated-cells, we noted numerous multi-vesicular 
bodies indicative of autophagy. Interestingly, we noted that the euchromatin and 
heterochromatin in nuclei of imipramine-treated cells had a different distribution than 
that of normal nuclei, suggesting potential epigenetic changes in addition to autophagy.  
Impact of ASM inhibition on autophagic flux 
 To investigate the effects of ASM inhibition on autophagic flux, we treated 
HPAEC with imipramine (50µM; 4 hours), using the following control conditions: 
untreated cells, vehicle treatment, and chloroquine (an autophagolysosome 
degradation or flux inhibitor). In addition, we used the PI3K inhibitor LY294002 (100µM) 
as a typical inhibitor of autophagy upstream of mTOR. If imipramine inhibits autophagic 
flux, we would expect treatment with choloroquine to not exacerbate the accumulation 
of LC3B-II or p62. On the contrary, if imipramine does not inhibit the flux, administration 
of chloroquine, which blocks the flux, will further increase LC3B-II levels when co-
administered with imipramine at the four hour time point. As expected, imipramine 
treatment increased LC3B-II, without a marked effect on p62 accumulation (Figure 5A). 
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The addition of chloroquine to imipramine, although not significantly affecting p62 
levels (Figure 5B), markedly increased LC3B-II accumulation when compared to 
imipramine alone, and effect which was statistically significant when quantified by 
densitometry (Figure 5C). This suggested that cells treated with imipramine do not 
exhibit an impaired autophagic flux. Interestingly, LY294002 did not inhibit autophagy 
induced by imipramine, suggesting imipramine may act downstream of PI3K to induce 
autophagy.  
ASM inhibition-induced autophagy is associated with mTOR signaling 
 To investigate if the mTOR pathway is affected by ASM inhibition, we used as a 
positive control rapamycin, a typical mTOR inhibitor, which  reduces the 
phosphorylation of P70 S6 kinase (p-S6k) that is needed for cap-dependent translation 
and cell cycle progression. We first performed a dose curve of rapamycin (50-500 nM) 
and determined its effect on S6k phosphorylation and autophagy (LC3BI lipidation) 
(Figure 6A). Rapamycin at concentrations of 100nM or 500nM increased levels of LC3B-II 
and decreased levels of LC3B-I, indicating autophagy. The PI3k inhibitor LY294002 
administered in concentrations of 100µM, but not of 50µM appeared to slightly reduce 
the conversion of LC3B-I to LC3B-II induced by rapamycin (100 nM; less so at 500 nM), 
without affecting the marked inhibitory effect of rapamycin on p-S6k. Interestingly, 
treatment with the ASM inhibitor imipramine, dose-dependently (Figure 6B) decreased 
p-S6k levels as early as 1 hour with a sustained effect for up to 24 hours (Figure 6C), 
indicating an important effect of ASM on mTOR activation.  
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Effect of ASM inactivation on fundamental cell functions, such as cell proliferation, 
viability, and apoptosis 
 We next determined if autophagy induced by ASM inhibition is associated with 
alterations in cell proliferation rates and overall cell fate. Since autophagy is typically 
associated with inhibition of cell proliferation (via mTOR pathway) we first measured 
thymidine incorporation in cells treated with imipramine and noted a mild reduction in 
cell proliferation at 24 hours, which was further impaired by adding a blocker of 
autophagy flux with chloroquine (Figure 7A). As expected, another autophagy inducer, 
the mTOR inhibitor rapamycin also reduced cell proliferation, whereas the PI3K inhibitor 
LY294002 uniformly and markedly lowered proliferation alone or when combined with 
other treatments. To understand if the imipramine-associated autophagy and decreased 
proliferation led to decreased cell viability, we used a CCK-8 assay, which is a measure of 
total intracellular dehydrogenase activity and is thus an indirect measure of viability. 
Imipramine-treated cells exhibited mild decreases in cellular viability at 24 hours, to a 
similar degree as those treated with chloroquine, whereas rapamycin-treated cells show 
a modest increase (Figure 7B). Finally, to determine if the mild decrease in cell 
proliferation and viability induced by the pro-autophagic imipramine is paralleled by an 
increase in apoptosis, we quantified externalization of phosphatidylserine at the plasma 
membrane using Annexin V staining. Imipramine-treated cells exhibited an increasing 
trend in apoptosis at 24 hours (Figure 7C). This effect was augmented by the addition of 
the PI3K inhibitor LY294002.  
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Figure 1 
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Figure 1 Mechanism of loss of mTOR signaling due to ASM inhibition 
 The mechanism of ASM inhibition involves its dissociation from the membrane 
and subsequent mTOR loss-of-function. The homeostatic relationship between survival 
and apoptosis is disrupted by a decrease in the cell’s ability to readily produce pro-
apoptotic ceramides from existing sphingomyelin pools with a concomitant loss of S6k 
phosphorylation producing misregulated cell survival/death signaling. 
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Figure 2 
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Figure 2 Treatment with imipramine reduces ASM activity 
HPAEC were treated for 4 hours with imipramine and ASM activity measured. 
Data represents single experiment. Imipramine diminishes ASM activity. 
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Figure 3A 
 
 
 
 
Figure 3B 
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Figure 3A Autophagy is induced in a dose-dependent manner 
 HPAEC were treated for four hours with indicated doses of imipramine. Whole 
cell lysates were used to probe for changes in LC3B-II and p62 via western blotting. 
Vinculin was used as a loading control. LC3B-II levels increase with 50 and 100µM 
treatment of imipramine. This is a representative image of three experiments. 
Figure 3B Quantification of western blot results 
 Image J was used to perform densitometry on protein bands in Figure 1A. LC3B-II 
had significant increase in the 50 and 100µM dosage. All LC3B-II levels were normalized 
by their respective vinculin loading controls. Data are represented as the average of 
three experiments, error bars represent standard error of the mean, n=3, ** = p ≤ 0.01, 
*** = p ≤ 0.001. 
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Figure 3C 
 
 
 
 
Figure 3D 
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Figure 3C Kinetics of imipramine induced autophagy 
 HPAEC were treated with 50µM imipramine for indicated periods of time. Whole 
cell lysates were used to probe for changes in LC3B-II and p62. Vinculin was used as a 
loading control. This is a representative image of three experiments. LC3B-II levels 
increase with imipramine treatment. 
Figure 3D Quantification of LC3B-II by densitometry 
 Image J was used to perform densitometry on protein bands in Figure 1C. LC3B-II 
had significant increase over that of control at the four and 24 hour time points. 
Although the average values of LC3B-II levels are higher at one and two hours are larger 
than their respective vehicle controls, the values are not significantly different. All LC3B-
II levels were normalized by their respective β-Actin loading control. Data are 
represented as the average of three experiments, error bars represent standard error of 
the mean, n=3, ** = p ≤ 0.01. 
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Figure 4A 
 
 
 
Figure 4B 
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Figure 4A Imipramine induces autophagy in BEAS2b cells 
 BEAS2b were treated with 50µM imipramine, 5µM FB1, or 50nM Myriocin for 
four hours in the presence of air control extract (A) or cigarette smoke extract (C). 
Whole cell lysates were used to probe for changes in LC3B-II and p62. β-Actin was used 
as a loading control. This is a representative image of six experiments. LC3B-II is 
increased in both air control and cigarette smoke treated cells that were exposed to 
imipramine. 
Figure 4B Quantification of LC3B-II by densitometry 
 Image J was used to perform densitometry on protein bands in Figure 4A. LC3B-II 
had significant increase over that of control. All LC3B-II levels were normalized by their 
respective β-Actin loading controls. Data represent averages of 6 experiments and error 
bars represent standard error of the mean, n=6, * = p ≤ 0.05. 
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Figure 4C 
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Figure 4C Electron microscopy of imipramine induced autophagy 
 BEAS2b cells were fixed and viewed by electron microscopy.  Organelles are 
marked by lower case letters e (endoplasmic reticulum), n (nucleus), m (mitochondria).  
Autophagosomes (a), lysosomes (l), and autophagolysosomes (al) are also marked.  The 
left two panels are control and the right two treated with 50µM imipramine. The scale 
bar represents 2µm in the top panels and 500nm in the bottom panels. The control 
panels show normal, healthy cells. The imipramine treated cells show an over-
abundance of multi-vesicular structures as well as changes in the distribution of 
euchromatin (light areas inside nucleus) and heterochromatin (dark areas inside 
nucleus) patterns indicating different epigenetic processes. Images are representative of 
10 images taken per treatment. 
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Figure 5A 
Figure 5B 
Figure 5C 
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Figure 5A Impact of ASM inhibition on autophagic flux 
 HPAEC were treated with 50µM imipramine for four hours with and without pre-
treatment with LY294002 or chloroquine. Whole cell lysates were used to probe for 
changes in LC3B-II and p62. Vinculin was used as a loading control. Image is 
representative of three experiments. LC3B-II is markedly increased with chloroquine 
treatment with or without the addition of imipramine over that of imipramine 
treatment alone. 
Figure 5B Quantification of LC3B-II by densitometry 
 Image J was used to perform densitometry on protein bands in Figure 5A. All 
LC3B-II levels were normalized by their respective vinculin loading controls. Addition of 
chloroquine to imipramine treatment resulted in a significant 3-fold increase in LC3B-II 
over imipramine treated cells and a significant 6-fold increase over vehicle. There was 
no significant difference between chloroquine and chloroquine with imipramine 
treatment or between imipramine and imipramine with LY294002 treatment. Data 
represent averages of 3 experiments and error bars represent standard error of the 
mean, n=3, n.s. = no significance, ** = p ≤ 0.01. 
Figure 5C Quantification of p62 by densitometry 
 Image J was used to perform densitometry on protein bands in Figure 5A. In the 
four hour experiment, p62 had significant increase only in the cells treated with both 
imipramine and chloroquine. All p62 levels were normalized by their respective vinculin 
loading controls. Data represent averages of 3 experiments and error bars represent 
standard error of the mean, n.s. = no significance, *** = p ≤ 0.001.  
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Figure 6A 
 
 
Figure 6B 
 
 
 
Figure 6C 
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Figure 6A Rapamycin and LY294002 effects on LC3B-II lipidation and P70 S6k 
phosphorylation 
 HPAEC were treated with varying concentrations of rapamycin and two 
concentration of rapamycin were chosen to also treat with two concentrations of 
LY294002. Whole cell lysates were used to probe for changes in LC3B-II and 
phosphorylated P70 S6k. Vinculin was used as a loading control. This image represents 
one experiment. Levels of LC3B-II were increased with the 100 and 500nM treatment of 
rapamycin.  Addition of 100µM LY294002 reduced LC3B-II levels induced by the 100nM 
rapamycin treatment. 
Figure 6B Dose dependent decrease in phosphorylated P70 S6k by imipramine 
 HPAEC were treated for four hours with indicated doses of imipramine. Whole 
cell lysates were used to probe for changes in phosphorylated P70 S6k. Vinculin was 
used as a loading control. Data is representative of one experiment. Phosphorylation of 
P70 S6k was reduced with 50 and 100µM treatments. 
Figure 6C Time dependent decrease in phosphorylated P70 S6k by imipramine 
 HPAEC were treated with 50µM imipramine for indicated periods of time. Whole 
cell lysates were used to probe for changes in phosphorylated P70 S6k. Vinculin was 
used as a loading control. Data is representative of one experiment. All 50µM 
imipramine treatments reduced the levels of phosphorylated P70 S6k. 
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Figure 7A 
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Figure 7A ASM inhibition decreases proliferation 
 HPAEC cells were incubated with tritiated thymidine under 24 hour experimental 
conditions and radioactive thymidine incorporation was quantified by scintillation 
counting. Data represents a single experiment performed in octuplicate. Imipramine and 
rapamycin treatments lowered proliferation while all treatments with LY294002 greatly 
reduced proliferation. 
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Figure 7B 
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Figure 7B ASM inhibition causes mild decrease in cell viability 
 HPAEC were incubated with indicated treatments for 24 hours and cell viability 
was indirectly measure by total dehydrogenase activity. Data represent a single 
experiment performed in octuplicate. Imipramine shows a slight decrease in number of 
viable cells. 
  
33 
 
Figure 7C 
  
34 
 
Figure 7C ASM inhibition exhibits slight increase in apoptosis 
 HPAEC were incubated with indicated treatments for 24 hours and total 
apoptotic events were measured by Annexin V staining. Data represent three 
experiments. Imipramine shows a slight, non-significant increase in number of apoptotic 
cells. 
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Discussion 
 Here we have shown that disruption of ASM from the lysosomal membrane 
induces autophagy associated with inhibition of mTOR signaling. This autophagic 
response is followed by decreased cell proliferation with a modest loss of cell viability 
and increased apoptosis. These results implicate ASM as an endogenous inhibitor of 
autophagy.  
 Our work was conducted in primary human lung endothelial and epithelial cells 
given our interest in the pathogenesis of lung diseases such as emphysema, a 
manifestation of chronic obstructive pulmonary disease characterized by airspace 
destruction through excessive apoptosis of these two types of structural cells. The 
implications of our findings to emphysema are yet to be determined. Typically, cigarette 
smoking induces both autophagy with an improper flux and apoptosis and activates 
ASM. Treatment with ASM inhibitors may alleviate apoptosis, but are unlikely to inhibit 
autophagy, rather they activate it. In addition, there are many individuals who are 
taking imipramine as an antidepressant. While adverse effects of this drug on lung 
function have not been reported, it would be interesting to investigate its effect on 
other conditions in which autophagy is important, such as lung or other cancers, 
neurodegenerative diseases, or adaptations to physical exercise. 
 Commonly, the research surrounding ASM is centered on the production of 
ceramide via activation of this enzyme. There is little known about the requirement for 
the homeostatic role of lysosomal ASM in cell fate or autophagy. We used the ASM 
inhibitor imipramine because it dissociates ASM from the membrane and diminishes its 
36 
 
activity without affecting other lysosomal hydrolases [16]. Using this inhibitor, our 
results suggest that fundamental mTOR dependent cell functions such as cell 
proliferation and translation are regulated by ASM presence in the lysosomal 
membrane. This conclusion will have to be confirmed in future studies using cell 
fractionation and immunofluorescence for ASM presence in the lysosomes as well as by 
molecular tools of lysosomal ASM loss and re-gain of function. 
 Our results are supported by a prior publication by Jeon et al. which showed that 
imipramine (used in similar concentrations as in our experiments) induced autophagic 
cell death in human glioma cells via mTOR inhibition [17]. In the context of this research, 
Wuwonqse et al. coupled synaptic degeneration with depression and autophagy-based 
removal of damaged synaptic proteins suggesting a therapeutic role for antidepressants 
[18]. In a study by Rossi et al., desmethylclomipramine, a similar drug to imipramine, 
induces accumulation of autophagic markers by blocking autophagic flux in HeLa cells 
[19]. Our study is performed in a primary, non-immortalized, non-cancerous lung cell 
line and co-treatment with imipramine and chloroquine shows a marked increase in 
abundance of LC3B-II over treatment with imipramine alone which suggests that 
autophagic flux is not impaired when autophagy is induced by ASM inhibition. 
 Imipramine and rapamycin appear to have similar effect on the signaling 
produced by the mTOR pathway by looking at LC3B-II and the downstream effector p-
S6k. While rapamycin directly inhibits mTOR from functioning, imipramine dissociates 
ASM from the lysosomal membrane indicating a mechanical relation between ASM and 
the mTOR complex.  The addition of chloroquine, a typical autophagic flux inhibitor, to 
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imipramine treatment markedly increased the presence of autophagosomes, indicating 
that ASM disruption induces autophagy without impairing the autophagic flux. 
 This report is limited by possible non-specific effects of a pharmacological 
inhibitor such as imipramine. A proper complement to this study would be that of small 
interfering RNA to prove specificity. Also, cell culture experiments are a great prelude to 
animal experiments, but are simple when compared to the complexity of an animal 
model. These limitations will be addressed in future, already planned experiments.  
 In conclusion, there is an intimate link between ASM and mTOR signaling which 
may regulate the onset and fate of autophagy. The ASM inhibitor imipramine is a potent 
inducer of autophagy that does not block autophagic flux and this effect may allow its 
application in conditions in which such an effect is desirable, such as conditions of 
improper protein folding. 
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